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R17the earliest identifier of the choice to
develop pluripotency and indeed
changing H3R26 methylation status,
changes the expression of pluripotency
genes and consequently cell fate.
Subsequent time-lapse studies of
unperturbed embryos revealed that the
progeny of the 4-cell blastomere shown
to have lowest H3R26 methylation
divides symmetrically, thus explaining
its biased contribution to
trophectoderm [19]. Finally and most
recently, 4-cell embryo blastomeres
were found to differ in kinetics of the
transcription factor Oct4 in a way that
further explains their differing fates
[20]. Collectively, these studies
strongly suggest that at least one cell of
the 4-cell embryo differs from the
others: this cell’s descendants initiate
differentiation earlier than those of the
other three cells.
Perhaps it is now time to accept that
cells in the mouse embryo do not
acquire identity in an entirely random
(stochastic) manner and that
differences between cells can arise as
early as the 4-cell stage. It is clear that
cells are still developmentally flexible at
this point, and even later, but left
undisturbed they seem to have
‘preferred’ paths. An attractive
hypothesis that might reconcile many
older and newer findings would be that
the mouse embryo cells are influenced
by where they come from and the
circumstances of their parents — they
have a memory of their developmental
history — but remain flexible enough
to adapt to life’s new circumstances.
This hypothesis illustrates the beauty
of this developmental system.
Numerous approaches have been
devised to show that embryo cells
taken from their native environment can
flourish when transplanted to new
sites; indeed cell properties change
upon isolation. What we now need to
find out is how these early cells begin to
acquire their differences in normal
development at a time that precedes
the impact of inside versus outside
positioning. This will be of great help in
understanding the first molecular steps
on a path to differentiation on one
hand, and on a path to pluripotency on
the other. What might the mechanism
be? Does it relate to polarisation of
the egg or of the zygote? If so, is it
influenced by the dramatic asymmetry
of the meiotic divisions, asymmetry
introduced by sperm entry at
fertilisation, or by the behaviour
of the male and female pronucleiin the first cell division? Whatever
the factor or factors, they are likely
to be quite subtle and so their
identification presents a challenge,
but an exciting one.
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KRas Down but Not OutRare codons selectively limit the accumulation of Ras family member proteins
with important consequences for Ras pathway activation and tumorigenesis.Brian O. Bodemann
and Michael A. White*
Orchestration of dynamic
cell-biological responses to regulatory
cues almost invariably mobilizes Ras
family small GTPases for signal
distribution and integration. This,together with the recognition that
KRAS is the most frequently
mutationally activated human
oncogene, has inspired intense efforts
to unravel the mechanistic details of
Ras-dependent signal transduction.
In humans, three genes (HRAS, KRAS,
andNRAS) encode four nearly identical
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Figure 1. Codon bias may select for the prevalence of KRas mutations in human cancers.
Rare codons limit KRas protein translation compared with HRas, which favors accumulation of the latter. Paradoxically, the otherwise subor-
dinate KRas protein may permit mutations at the KRAS locus to escape tumor suppressor surveillance mechanisms. Codon-biased mutant
KRas protein is thus free to drive neoplasia en route to tumorigenesis.
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R18proteins — HRas, NRas, and the
splicing variants KRas4A and KRas4B.
By all accounts, there is little that
discriminates these proteins at the
biochemical level: they appear to be
governed by a common cohort of
regulators and supported by the same
suite of effectors. While this smacks of
‘functional redundancy’, two genetic
observations ostensibly argue for
selective participation of Ras family
members in development and
disease. First, homozygous deletion of
KRAS in mice is embryonic lethal,
whereas even compound deletion of
HRAS and NRAS is tolerated [1–3].
Second, there is a dramatic asymmetry
in the frequency of representation of
oncogenic Ras alleles in different tumor
types: KRAS has the highest incidence
in pancreatic adenocarcinomas (95%)
[4], non-small cell lung cancer
(15–20%) [5], and colon adenomas
(40%) [6]; NRAS mutations appear in
hematological malignancies (20–30%)
[7] and melanomas (15%) [8]; andthyroid malignancies harbor mutations
in HRAS, KRAS, or NRAS [9].
Consequently, significant effort has
been invested in parsing the public
versus private occupations of Ras
family proteins in order to discover
what is special about KRas.
One of the most discriminatory
features of KRas is a distinctive
subcellular localization pattern
compared with that of its brothers
HRas and NRas. Ras protein tethering
to the plasma membrane and/or
endomembranes is required for
function [10]. The major addressing
mechanism for HRas, NRas, and
KRas4A is post-translational
modification of the carboxyl terminus,
with a combination of a farnesyl
moiety and palmitoylation [11,12].
In contrast, the KRAS4B-specific
exon encodes a tail that is farnesylated
but has a charged polylysine
domain instead of the palmitoylation
signal [13]. As a consequence,
KRas4B bypasses the conventionalGolgi secretory pathway to reach
the plasma membrane where it is
enriched in microdomains that are
distinct from those containing HRas
and NRas [14]. This spatial segregation
is thought to account, at least in part,
for a selective capacity of KRas4B to
engage downstream effector
pathways [14].
However, these subtleties of
regulation may fall by the wayside
within some of the most important
developmental and pathological
contexts. This point was driven home
with a series of gene replacement
studies in themouse by Allan Balmain’s
group. First, the embryonic lethality of
homozygous KRAS deletion in mice
was rescued by inserting the HRAS
coding sequence into the KRAS
locus, indicating that HRas protein
can fully support embryonic
development if expressed with the
appropriate timing [15]. Second,
these HRAS knock-in mice were
fully sensitive to urethane-induced
Dispatch
R19lung cancer, a phenotype that is
normally exclusively associated with
activating mutations in KRAS [15].
Remarkably, the lung tumors in the
HRAS knock-in animals harbored
activating mutations only in HRAS
within the KRAS locus, indicating
that HRas can fully support
tumorigenesis of the lung [15].
Therefore, the frequency of
representation of mutations in distinct
Ras family members in different
tumor types may not be reflective
of distinctive biochemical activities
as much as it is reflective of differential
mutability of the respective genes in
different tissues.
In this issue of Current Biology, Chris
Counter’s group reports another
previously unappreciated layer of Ras
family regulation that also accounts for
distinct Ras family protein activity
through distinct contextual features as
opposed to biochemical features [16].
Through an investigation springing
from sophisticated serendipity, the
authors discovered that KRAS is
poorly translated compared with HRAS
due to stalling of ribosomes on
genomically under-represented or rare
codons, which are selectively enriched
in KRAS transcripts. Converting the
rare codons in KRAS to common ones
alleviated ribosome stalling and
increased the accumulation of KRas
protein to concentrations comparable
to those observed for HRas. The
biological consequence of codon
usage was indicated by the
observation that HEK-HT cells
ectopically expressing a constitutively
active form of KRas, KRas(G12V),
formed tumors in mice that were
w90-fold smaller than those derived
from cells ectopically expressing
HRas(G12V). This difference was
normalized by ectopic expression of
the codon-optimized KRas(G12V)
variant. When this codon-optimized
form of KRas(G12V) was knocked
into the KRAS locus of HCT116 cells,
their tumor-forming potential
increasedw30-fold compared with the
knock-in control harboring the native
complement of rare codons. The
finding that KRAS mutation initially
delivers a weak oncogene may
seem counter-intuitive; however,
KRas4B(G12V) can induce apoptosis
when phosphorylated at Ser181
and sustained high-amplitude
activation of the Raf–MAPK Ras
effector pathway can induce
cellular senescence through theaccumulation of cyclin-dependent
kinase inhibitors [17–19]. Thus, the
mechanistic irony is that rare codons
may limit KRas expression to
concentrations that are below the
threshold of anti-neoplastic checkpoint
mechanisms but that are sufficient to
induce hyperplasia and a regulatory
environment permissive to tumor
initiation (Figure 1).
Of great interest will be the
elaboration of the regulatory axes that
may leverage codon bias to modulate
Ras protein function in support of
distinct physiological processes.
As alluded to above, KRAS is required
for embryonic development and the
protein is detectable in a variety of
embryonic tissues, suggesting the
presence of mechanisms that
compensate for codon-limited KRas
expression. As indicated by the
authors, a variety of potential
compensation mechanisms have been
described, including miRNA
regulation, enhanced tRNA
production, and — at least in the
setting of disease — gene
amplification. By extension, the
commonality of selective regulation of
homologous proteins through codon
bias is also an important open
question. To begin to address this,
Counter and colleagues [16] performed
a genome-wide survey for gene
pairs encoding proteins with high
amino-acid identity but employing
opposing codon bias. This analysis
returned at least 60 gene pairs,
two of which (CFL1/2 and ORMDL1/3)
were demonstrated to produce
gene products that were selectively
limited by the opposing codon bias.
Of interest, the cohort of gene pairs
was enriched for loci encoding
purine nucleotide-binding proteins,
including kinases and GTPases,
indicating a prevalence of codon
bias associated with homologous
signaling proteins. This work gives
a clear indication that codon bias
can play an important role in shaping
protein expression profiles. There
are 22 mitochondrial tRNA genes
and 450 annotated nuclear genes
encoding cytoplasmic tRNA
molecules [20]. Investigation of the
heterogeneity of tRNA expression in
animals and its consequence on the
assembly of regulatory systems will
likely shed additional light on the
contribution of codon bias to the
time and tissue specificity of protein
expression.References
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eduhttp://dx.doi.org/10.1016/j.cub.2012.11.054Neuroecology: A Fly’s Bug DetectorDrosophila avoid food contaminated by pathogenic bacteria and fungi using an
olfactory pathway that is exquisitely tuned to a single microbial odour.Lucia L. Prieto-Godino
and Richard Benton*
Humans, like most animals, must battle
constantly against harmful bacteria
or fungi that enjoy living off our food,
or off us. An important line of defence
is the immune system, which detects
pathogens on or within the body. A
shrewder strategy for animals,
however, would be to avoid contact
with dangerous microorganisms
altogether. One way we manage this is
through our sense of smell: communal
fridges in laboratory cafe´s provide
clear, unappealing, olfactory signals of
long-forgotten contents succumbing to
the appetites of microscopic feeders.
However, most of these smells are
complex blends of dozens of odours
produced by both pathogenic and
non-pathogenic microorganisms.
Can olfactory systems unequivocally
indicate the presence of toxic
microbes? In a new study [1], Marcus
Stensmyr, Bill Hansson and colleagues
identify an olfactory pathway in the
fruit fly Drosophila melanogaster
that is specifically tuned to
a pathogenic microbial product and
induces robust behavioural
counter-measures (Figure 1).
Drosophila melanogaster feeds
mainly on harmless yeast strains
growing on fermenting fruit [2,3]. Such
food sources are, however, also
attractive culture conditions for
dangerous microorganisms, including
the ubiquitous Streptomyces bacteria
and Penicillium fungal moulds. Indeed,
Stensmyr and colleagues [1] show that
contaminating laboratory Drosophila
food with either Streptomyces
coelicolor or Penicillium expansum
leads to death of flies within a few days,
probably because these microbesproduce toxic metabolites or
outcompete the yeast in the medium.
Importantly, when given the choice
between food containing or lacking
S. coelicolor, flies avoid feeding and
laying eggs on the tainted medium.
How do flies detect these
pathogens? One common metabolic
product of both Streptomyces and
Penicillium species is geosmin (‘earth
smell’ in Greek), a volatile chemical that
is recognisable to humans as the scent
emanating from soil after rainfall. The
authors [1] considered geosmin as an
interesting candidate for the aversive
olfactory signal, as previous work had
shown this compound could suppress
attraction of Drosophila to vinegar
volatiles [4]. In the new study, Stensmyr
et al. [1] use a battery of assays to
demonstrate that geosmin has
numerous potent effects on behaviour:
flies run away or freeze when exposed
to geosmin, normally highly palatable
sugar solutions are refused when
spiked with this chemical, and
females avoid laying eggs near
geosmin-scented medium (Figure 1).
The effects of geosmin are
impressive, but is this the compound
that flies use to recognise and avoid
toxic microbes? Or do they rely on
a combination of volatiles to detect the
presence of these pathogens? The
authors elegantly address these
questions by making use of a mutant
S. coelicolor strain that lacks an
enzyme required for geosmin
biosynthesis [5]. Remarkably, this
strain no longer repels flies from
feeding or egg-laying, despite the
presence of other toxic chemicals that
would ultimately kill them. This
observation provides strong evidence
that geosmin is a natural — and
possibly the only — chemical cue usedby Drosophila to avoid substrates
infected with this pathogenic
bacterium.
How do flies detect geosmin?
Stensmyr et al. [1] perform an
impressively comprehensive screen of
the Drosophila olfactory system by
electrophysiological recordings and
calcium imaging of neuronal responses
to this odour. Strikingly, geosmin
activates only one class of olfactory
sensory neuron, which expresses
the odorant receptor OR56a
(Figure 1). This receptor was one of
a handful of ‘orphan’ odorant
receptors, for which ligands had
not been identified in earlier screens
of off-the-shelf chemicals [6,7], hinting
that it might be narrowly-tuned to
geosmin. The authors provide
spectacular confirmation of this
hypothesis by recording the activity
of OR56a neurons while presenting
them with the complex chemical
bouquets — separated and identified
by gas chromatography coupled to
mass spectrometry — from diverse
natural sources, including fruits,
faeces, vinegar and rotting meat.
Only three sources activate OR56a
neurons: a moss tussock, a mouldy
tomato and a culture of S. coelicolor.
Amongst the hundreds of volatiles
produced by each of these sources,
only a single compound appears
responsible for this activity: geosmin.
Together, these experiments provide
compelling evidence that flies
detect geosmin — and only
geosmin — through OR56a neurons.
Stensmyr et al. [1] then used the
promoter of OR56a to selectively drive
expression of an inhibitor of neuronal
activity in this population of neurons
to ask whether this sensory pathway
is necessary for geosmin-evoked
behaviours. Indeed, silencing of these
neurons abolishes avoidance of
geosmin and suppresses the aversive
influence of this compound on feeding.
In addition, these flies now lay eggs
upon medium containing S. coelicolor
as readily as uncontaminated medium,
